Duration of treatment with bisphosphonates at the time of osteonecrosis of the jaw onset in patients with rheumatoid arthritis. Review.
Fiche publication
Date publication
janvier 2018
Journal
Journal of stomatology, oral and maxillofacial surgery
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ZWETYENGA Narcisse
Tous les auteurs :
Compain H, Berquet A, Loison-Robert LS, Ahossi V, Zwetyenga N
Lien Pubmed
Résumé
Rheumatoid arthritis (RA) is a frequent and co-morbid condition. One of the main complications is induced osteoporosis. Treatments related to this complication significantly modify oral and implant management. Affected patients represent a population at intermediate risk of osteonecrosis of the jaw (ONJ). The objective was to search the literature for durations of treatment with bisphosphonates at the time of ONJ occurrence in patients with RA in order to obtain an average duration.
Mots clés
Bisphosphonate, Implantology, Oral surgery, Osteonecrosis of the jaw, Rheumatoid arthritis
Référence
J Stomatol Oral Maxillofac Surg. 2018 Jan 8;: